Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
Adenocarcinoma in Situ
×
Clear all
Filters
3
NCT03546842
2020-02-25
V503-017
Merck Sharp & Dohme LLC
Phase 3
Completed
201 enrolled
11 charts